Autor: "Liesveld J" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease.
Autorzy:: Bachanova V; Blood and Marrow Transplant Program, University of Minnesota Medical Center, Minneapolis, MN, USA.
Marks DI; Bristol Adult BMT Unit, Bristol Children's Hospital, Bristol, UK.
Zhang MJ; Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA.
Wang H; Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA.
de Lima M; Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
Aljurf MD; Department of Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Arellano M; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Artz AS; Department of Hematology and Oncology, University of Chicago Medicine, Chicago, IL, USA.
Bacher U; Klinik und Poliklinik fur Stammzelltransplantation, Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Cahn JY; Department of Hematology, University Hospital, Grenoble, France.
Chen YB; Department of Bone Marrow Transplantation, Massachusetts General Hospital, Boston, MA, USA.
Copelan EA; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.
Drobyski WR; Medical College of Wisconsin, Milwaukee, WI, USA.
Gale RP; Imperial College, Section of Hematology, Division of Experimental Medicine, Department of Medicine, London, UK.
Greer JP; Department of Hematology and Stem Cell Transplantation, Vanderbilt University Medical Center, Nashville, TN, USA.
Gupta V; Princess Margaret Hospital, Toronto, Ontario, Canada.
Hale GA; Department of Pediatric Hematology and Oncology, All Children's Hospital, St Petersburg, FL, USA.
Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX, USA.
Lazarus HM; Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
Lewis ID; Department of Haematology and Bone Marrow Transplant Unit, Royal Adelaide Hospital/SA Pathology, Adelaide, South Australia, Australia.
Lewis VA; Department of Hematology and Oncology, Alberta Children's Hospital, Calgary, Alberta, Canada.
Liesveld JL; Department of Hematology and Oncology, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY, USA.
Litzow MR; Department of Hematology and Internal Medicine, Mayo Clinic Rochester, Rochester, MN, USA.
Loren AW; Department of Hematology and Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Miller AM; Department of Oncology, Baylor University Medical Center, Dallas, TX, USA.
Norkin M; Department of Hematology and Oncology, Shands HealthCare and University of Florida, Gainesville, FL, USA.
Oran B; Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX, USA.
Pidala J; Department of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.
Rowe JM; Department of Hematology, Rambam Medical Center, Haifa, Israel.
Savani BN; Department of Hematology and Stem Cell Transplantation, Vanderbilt University Medical Center, Nashville, TN, USA.
Saber W; Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI, USA.
Vij R; Department of Bone Marrow Transplantation and Leukemia, Barnes Jewish Hospital, Washington University School of Medicine, St Louis, MO, USA.
Waller EK; Bone Marrow and Stem Cell Transplant Center, Emory University Hospital, Atlanta, GA, USA.
Wiernik PH; Our Lady of Mercy Medical Center, Bronx, NY, USA.
Weisdorf DJ; Blood and Marrow Transplant Program, University of Minnesota Medical Center, Minneapolis, MN, USA.; Pokaż więcej
Źródło:: Leukemia [Leukemia] 2014 Mar; Vol. 28 (3), pp. 658-65. Date of Electronic Publication: 2013 Aug 30.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Bone Marrow Transplantation*
Neoplasm, Residual*
Philadelphia Chromosome*
Remission Induction*
Survival Rate*
Transplantation Conditioning*
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*surgery
Protein-Tyrosine Kinases/*antagonists & inhibitors
Adult ; Animals ; Female ; Guinea Pigs ; Humans ; Male ; Middle Aged ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Transplantation, Homologous ; Young Adult